210 related articles for article (PubMed ID: 9207866)
21. Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma.
Bordow SB; Haber M; Madafiglio J; Cheung B; Marshall GM; Norris MD
Cancer Res; 1994 Oct; 54(19):5036-40. PubMed ID: 7923112
[TBL] [Abstract][Full Text] [Related]
22. Combined determination of N-myc oncogene amplification and DNA ploidy in neuroblastoma. Complementary prognostic indicators.
Muraji T; Okamoto E; Fujimoto J; Suita S; Nakagawara A
Cancer; 1993 Nov; 72(9):2763-8. PubMed ID: 8402501
[TBL] [Abstract][Full Text] [Related]
23. [Oncogene amplification in human neuroblastomas].
Kanda N; Tsuchida Y; Hayashi Y; Ise T; Takayama J; Utakoji T
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):661-6. PubMed ID: 3963837
[TBL] [Abstract][Full Text] [Related]
24. Trk mRNA and low affinity nerve growth factor receptor mRNA expression and triploid DNA content in favorable neuroblastoma tumors.
Kogner P; Barbany G; Björk O; Castello MA; Donfrancesco A; Falkmer UG; Hedborg F; Kouvidou H; Persson H; Raschella G
Prog Clin Biol Res; 1994; 385():137-45. PubMed ID: 7972205
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells.
Fan L; Iyer J; Zhu S; Frick KK; Wada RK; Eskenazi AE; Berg PE; Ikegaki N; Kennett RH; Frantz CN
Cancer Res; 2001 Feb; 61(3):1073-9. PubMed ID: 11221835
[TBL] [Abstract][Full Text] [Related]
26. The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2.
Godfried MB; Veenstra M; v Sluis P; Boon K; v Asperen R; Hermus MC; v Schaik BD; Voûte TP; Schwab M; Versteeg R; Caron HN
Oncogene; 2002 Mar; 21(13):2097-101. PubMed ID: 11960382
[TBL] [Abstract][Full Text] [Related]
27. Over-expression of transfected N-myc oncogene in human SKNSH neuroblastoma cells down-regulates expression of beta 1 integrin subunit.
Judware R; Culp LA
Oncogene; 1995 Dec; 11(12):2599-607. PubMed ID: 8545117
[TBL] [Abstract][Full Text] [Related]
28. Neuroblastoma: inhibition of progression (Part II). Basic science in pediatric surgery.
Girgert R; Wittrock J; Schweizer P
Eur J Pediatr Surg; 2001 Dec; 11(6):363-7. PubMed ID: 11807663
[TBL] [Abstract][Full Text] [Related]
29. Flow cytometric and molecular analysis of proliferative activity and DNA content in neuroblastoma: presence of stationary cells in S-phase.
Dominici C; Negroni A; Romeo A; McDowell H; Padula A; Pucci S; Cappelli C; Castello MA; Raschellà G
Anticancer Res; 1992; 12(1):59-63. PubMed ID: 1567182
[TBL] [Abstract][Full Text] [Related]
30. High-resolution mapping of the N-myc amplicon core domain in neuroblastomas.
Hiemstra JL; Schneider SS; Brodeur GM
Prog Clin Biol Res; 1994; 385():51-7. PubMed ID: 7972237
[TBL] [Abstract][Full Text] [Related]
31. Electron microscopic localization of acridine orange binding to euchromatin in human neuroblastoma cells.
Hiroi M; Moriki T; Taniguchi T; Yamane T; Lehmann R; Hara H
Zentralbl Pathol; 1991; 137(1):20-8. PubMed ID: 1905567
[TBL] [Abstract][Full Text] [Related]
32. Detection of n-myc gene amplification in neuroblastoma by comparative, in situ,and real-time polymerase chain reaction.
Melegh Z; Bálint I; Tóth E; Csernák E; Szentirmay Z; Nagy K
Pediatr Pathol Mol Med; 2003; 22(3):213-22. PubMed ID: 12746172
[TBL] [Abstract][Full Text] [Related]
33. N-myc amplification and cell proliferation rate in human neuroblastoma.
Pession A; Trerè D; Perri P; Rondelli R; Montanaro L; Mantovani W; Derenzini M; Paolucci G
J Pathol; 1997 Nov; 183(3):339-44. PubMed ID: 9422991
[TBL] [Abstract][Full Text] [Related]
34. Improved survival for patients with advanced neuroblastoma after high-dose combined chemotherapy based in part on N-myc amplification.
Suita S; Tajiri T; Sera Y; Takamatsu H; Mizote H; Nagasaki A; Kurosaki N; Hara T; Okamura J; Miyazaki S; Sugimoto T; Kawakami K; Eguchi H; Tsuneyoshi M
J Pediatr Surg; 2000 Dec; 35(12):1737-41. PubMed ID: 11101726
[TBL] [Abstract][Full Text] [Related]
35. Increased expression of the proto-oncogene, c-myc, in human neuroblastoma cells by reversible inhibition of cell growth.
Fukuchi K; Tomoyasu S; Watanabe K; Suzuki H; Kaetsu T; Takagi Y; Tsuruoka N; Gomi K
Anticancer Res; 1991; 11(6):1967-73. PubMed ID: 1776829
[TBL] [Abstract][Full Text] [Related]
36. Neuroblastoma with DNA amplification and rearrangement in the N-myc gene region.
Hiyama E; Hiyama K; Yokoyama T
Cancer Res; 1991 Apr; 51(7):1946-51. PubMed ID: 2004381
[TBL] [Abstract][Full Text] [Related]
37. Multiple amplicons of discrete sizes encompassing N-myc in neuroblastoma cells evolve through differential recombination from a large precursor DNA.
Amler LC; Schwab M
Oncogene; 1992 Apr; 7(4):807-9. PubMed ID: 1565478
[TBL] [Abstract][Full Text] [Related]
38. Flow cytometric DNA analysis of neuroblastoma--clinical significance of DNA tetraploidy.
Naito M; Iwafuchi M; Hirota M
Prog Clin Biol Res; 1994; 385():87-93. PubMed ID: 7972240
[No Abstract] [Full Text] [Related]
39. Loss of one HuD allele on chromosome #1p selects for amplification of the N-myc proto-oncogene in human neuroblastoma cells.
Grandinetti KB; Spengler BA; Biedler JL; Ross RA
Oncogene; 2006 Feb; 25(5):706-12. PubMed ID: 16278682
[TBL] [Abstract][Full Text] [Related]
40. In vivo regulation of single copy and amplified N-myc in human neuroblastoma cells.
Lutz W; Schwab M
Oncogene; 1997 Jul; 15(3):303-15. PubMed ID: 9233765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
